Golcadomide ± Rituximab in Relapsed/Refractory Large B-cell Lymphoma | Julio Chavez, MD, MS | #ASH24

Golcadomide ± Rituximab in Relapsed/Refractory Large B-cell Lymphoma | Julio Chavez, MD, MS | #ASH24
Mosunetuzumab + Polatuzumab Shows Promising Outcomes in LBCL | Julio Chavez, MD, MS | #ASH24
Promising Results for CAR-T Cell therapy for Follicular Lymphoma | Matthew Frank, MD, PhD | #ASH24
What are some newer drug classes being studied to treat follicular lymphoma?
Allogeneic & Autologous Stem Cell Transplant for Follicular Lymphoma | Yasmina Serroukh, MD | #ASH24
Odronextamab as First-Line Therapy in Follicular Lymphoma | Rueme Birhiray, MD | #ASH24
CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24
Real-World Impact of CAR-T Therapy on DLBCL: Insights & Future Research | Lisa Herms, PhD | #ASH24
Novel CAR-T Attacks New Target in Relapsed LBCL | Anne Kramer, MD, PhD | #ASH24
Fludarabine vs. Bendamustine Lymphodepletion Prior to CAR-T for LBCL | Alaa Ali, MD | #ASH24
Rituximab for Low Tumor Burden Follicular Lymphoma | Noriko Fukuhara MD, PhD | #ASH24